CA1031262A - Corticosteroid phosphate salts/neomycin sulfate ophthalmic solution - Google Patents

Corticosteroid phosphate salts/neomycin sulfate ophthalmic solution

Info

Publication number
CA1031262A
CA1031262A CA205,470A CA205470A CA1031262A CA 1031262 A CA1031262 A CA 1031262A CA 205470 A CA205470 A CA 205470A CA 1031262 A CA1031262 A CA 1031262A
Authority
CA
Canada
Prior art keywords
corticosteroid
ophthalmic solution
phosphate salts
neomycin sulfate
sulfate ophthalmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA205,470A
Other languages
English (en)
French (fr)
Inventor
James W. Mcginity
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of CA1031262A publication Critical patent/CA1031262A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA205,470A 1973-08-01 1974-07-23 Corticosteroid phosphate salts/neomycin sulfate ophthalmic solution Expired CA1031262A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US384551A US3898330A (en) 1973-08-01 1973-08-01 Corticosteroid phosphate salts/neomycin sulfate ophthalmic

Publications (1)

Publication Number Publication Date
CA1031262A true CA1031262A (en) 1978-05-16

Family

ID=23517768

Family Applications (1)

Application Number Title Priority Date Filing Date
CA205,470A Expired CA1031262A (en) 1973-08-01 1974-07-23 Corticosteroid phosphate salts/neomycin sulfate ophthalmic solution

Country Status (12)

Country Link
US (1) US3898330A (enExample)
JP (1) JPS5042026A (enExample)
BE (1) BE818410A (enExample)
CA (1) CA1031262A (enExample)
DE (1) DE2437145A1 (enExample)
DK (1) DK134924B (enExample)
FR (1) FR2240013B1 (enExample)
GB (1) GB1471326A (enExample)
NL (1) NL7410297A (enExample)
NO (1) NO141394C (enExample)
SE (1) SE7409891L (enExample)
ZA (1) ZA744703B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
JPS56150012A (en) * 1980-03-21 1981-11-20 Wellcome Found Isotomic solution medicine
US5883074A (en) * 1995-02-08 1999-03-16 Microcide Pharmaceuticals, Inc. Potentiators of antibacterial agents
US6843983B2 (en) * 2001-06-07 2005-01-18 Virgie Bright-Ellington Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae
CN106075449A (zh) 2005-07-14 2016-11-09 尼奥塞蒂克斯公司 用于局部脂肪组织治疗的持续释放的增强性脂肪分解性制剂
AU2007313077B2 (en) * 2006-10-17 2011-06-02 Neothetics, Inc. Methods, compositions, and formulations for the treatment of thyroid eye disease
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
BR112013012994A2 (pt) 2010-11-24 2016-09-13 Lithera Inc formulações monoterapêuticas de beta-agonista de longa duração, lipofílicas e seletivas e métodos para o tratamento cosmético da adiposidade e saliência de contorno
BR102012030828A2 (pt) 2012-12-03 2014-09-16 Ems Sa Composição farmacêutica compreendendo desloratadina e prednisolona e seu uso

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3105795A (en) * 1957-02-12 1963-10-01 Schering Corp 9alpha-fluoro-15beta-hydroxy-1, 4-pregnadienes and pharmaceutical preparations containing same
US3146164A (en) * 1960-08-09 1964-08-25 Merck & Co Inc Solutions of steroid phosphate and basic antibiotics stabilized with creatinine
US3138528A (en) * 1962-05-01 1964-06-23 Olin Mathieson Stable, aqueous solutions of 21-phosphate esters of 21-hydroxy steroids
US3317384A (en) * 1964-06-08 1967-05-02 Upjohn Co Treatment of topical viral infections with glucocorticoids and nucleosides

Also Published As

Publication number Publication date
SE7409891L (enExample) 1975-02-03
FR2240013B1 (enExample) 1977-11-04
NO141394B (no) 1979-11-26
US3898330A (en) 1975-08-05
DE2437145A1 (de) 1975-02-13
DK134924C (enExample) 1977-08-01
ZA744703B (en) 1975-07-30
NL7410297A (nl) 1975-02-04
DK409774A (enExample) 1975-04-01
DK134924B (da) 1977-02-14
BE818410A (fr) 1975-02-03
NO742767L (enExample) 1975-03-03
FR2240013A1 (enExample) 1975-03-07
NO141394C (no) 1980-03-05
GB1471326A (en) 1977-04-21
JPS5042026A (enExample) 1975-04-16
AU7159874A (en) 1976-01-29

Similar Documents

Publication Publication Date Title
CA1021285A (en) Reusable shields for selective electrodeposition
CA928445A (en) Continuous process for preparing noncellular polyurethanes
CA1032480A (en) Plate dialyzer
AU475779B2 (en) New antibacterial agents
CA1030287A (en) Paper-sizing agents
AU509331B2 (en) Ophthalmic inserts
ZA744703B (en) Corticosteroid phosphate salts/ neomycin sulfate ophtalmic solution
CA1025708A (en) Fastening pins
CA1022541A (en) Pregnane acid derivatives
CA1017274A (en) Antibiotic av290-alkyl sulfate complex
AU483525B2 (en) Corticosteroid phosphate salts neomycin sulfate ophthalmic solution
CA1007221A (en) Pregnane acid derivatives
AU468382B2 (en) Chenodeoxycholic acid
AU473140B2 (en) New sulfamylbenzoic acid derivatives
CA1005216A (en) Partitions
AU484411B2 (en) Antibacterial agents anda process for their preparation
AU480636B2 (en) New pregnane acid derivatives
AU471234B2 (en) New sulfamylbenzoic acid derivatives
AU475111B2 (en) Diagnostic agents
AU460982B2 (en) Diaper fastener
AU467452B2 (en) Phosphonic acid salts
AU482224B2 (en) Steroid formulation
AU480065B2 (en) Benzoyl-phenylacetic acid derivatives
ZA742355B (en) New pregnane acid derivatives
AU471581B2 (en) New 16-hydroxy-17-aminosteroids